Search

Your search keyword '"Andreis A."' showing total 21 results
Start Over Author "Andreis A." Journal annals of oncology
21 results on '"Andreis A."'

3. Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Author

Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, Falci C, V., Giarratano, T, Mcmahon, L, De Salvo GL, Dieci, Mv, Maiorana, A, Ficarra, G, Caggia, F, Grisolia, D, Bartolini, S, Lorusso, V, Ardito, R, Tartarone, A, Vanella, P, Taverniti, C, Porpiglia, M, Spanu, Pg, Biglia, N, Andreis, D, Piancastelli, A, Fedeli, A, Parra, Hs, Gambaro, Ar, Romito, S, Malossi, A, Gori, S, Miglietta, L, Del Mastro, L, Amoroso, D, Mansutti, M, Generali, D, Prati, G, Bertolini, A, Berardi, R, Zanni, A, Cottafavi, L, Bologna, A, Naso, G, Pancotti, A, Farci, D, Zoboli, A, Silva, R, Laudadio, L, Bordonaro, R, Marenco, D, Dongiovanni, V, Baldini, E, Saggia, C, Gorzegno, G, Cariello, A, Biganzoli, L, Rampello, E., Conte P., Frassoldati A., Bisagni G., Brandes A.A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E.A., Vicini R., Balduzzi S., D'Amico R., and Guarneri V.

Subjects
Oncology, Time Factors, Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab, Settore MED/06 - Oncologia Medica, Receptor, ErbB-2, medicine.medical_treatment, Anthracycline, 030204 cardiovascular system & hematology, Breast cancer, Antineoplastic Agents, Immunological, ErbB-2, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Anthracyclines, skin and connective tissue diseases, Adjuvant, Mastectomy, Cardiac safety, De-escalated treatment, Hazard ratio, Hematology, Middle Aged, Chemotherapy regimen, Bridged-Ring Compound, Immunological, Local, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Taxoids, Trastuzumab, adjuvant, breast cancer, cardiac safety, de-escalated treatment, Breast Neoplasm, Human, Receptor, medicine.drug, Adult, Bridged-Ring Compounds, medicine.medical_specialty, Time Factor, Socio-culturale, Breast Neoplasms, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Taxoid, Internal medicine, medicine, Humans, Chemotherapy, Risk factor, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, medicine.disease, Cardiotoxicity, Neoplasm Recurrence, Neoplasm Recurrence, Local, business
Abstract

Background: Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended trastuzumab exposure is under investigation. The short-HER study was aimed to assess the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy. Patients and methods: HER2-positive breast cancer patients with node-positive or, if node negative, with at least one risk factor (pT>2 cm, G3, lympho-vascular invasion, Ki-67 > 20%, age 35 years, or hormone receptor negativity) were randomly assigned to receive sequential anthracycline-taxane combinations plus 1-year trastuzumab (arm A, long) or plus 9 weeks trastuzumab (arm B, short). This study was designed as a non-inferiority trial with disease-free survival (DFS) as primary end point. A DFS hazard ratio (HR)

Published
2018
Full Text
View/download PDF

4. Corrections to “Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors”

Author

Soria, J.-C., primary, Cortes, J., additional, Massard, C., additional, Armand, J.-P., additional, De Andreis, D., additional, Ropert, S., additional, Lopez, E., additional, Catteau, A., additional, James, J., additional, Marier, J.-F., additional, Beliveau, M., additional, Martell, R.E., additional, and Baselga, J., additional

Published
2019
Full Text
View/download PDF

7. Is Androgen Receptor a predicitive biomarker of response to antiestrogen therapy in advanced breast cancer?

Author

Ravaioli, S., primary, Rocca, A., additional, Bronte, G., additional, Puccetti, M., additional, Tumedei, M.M., additional, Scarpi, E., additional, Maltoni, R., additional, Sarti, S., additional, Cecconetto, L., additional, Andreis, D., additional, Pietri, E., additional, Calistri, D., additional, Amadori, D., additional, and Bravaccini, S., additional

Published
2017
Full Text
View/download PDF

8. Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra-patient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program

Author

Gennari, A., primary, Brain, E., additional, Nanni, O., additional, Muñoz Couselo, E., additional, Harbeck, N., additional, Geiss, R., additional, Rocca, A., additional, Cortés, J., additional, Degenhardt, T., additional, Piccardo, A., additional, Albérini, J-L., additional, Matteucci, F., additional, Decensi, A., additional, Corradengo, D.S., additional, Andreis, D., additional, Marra, D., additional, Gebhart, G., additional, Brambati, C., additional, Amadori, D., additional, and Bruzzi, P., additional

Published
2017
Full Text
View/download PDF

9. Dignity Therapy: a new psychoterapeutic approach for people facing advanced disease

Author

Chiara Ogliosi, E Gadaldi, A. Zaniboni, Tiziana Prochilo, Silvia Noventa, Federica Andreis, Fausto Meriggi, Paola Bertocchi, B. Di Biasi, Francesca Aroldi, Chiara Abeni, Mara Mirandola, Michela Libertini, and Luigina Rota

Subjects
medicine.medical_specialty, Oncology, business.industry, Advanced disease, Medicine, Hematology, business, Intensive care medicine
Published
2017
Full Text
View/download PDF

10. Is Androgen Receptor a predicitive biomarker of response to antiestrogen therapy in advanced breast cancer?

Author

Lorenzo Cecconetto, Giuseppe Bronte, Emanuela Scarpi, Sara Bravaccini, Samanta Sarti, Maria Maddalena Tumedei, Maurizio Puccetti, Elisabetta Pietri, Roberta Maltoni, D Andreis, Dino Amadori, Daniele Calistri, Andrea Rocca, and S. Ravaioli

Subjects
Oncology, medicine.medical_specialty, business.industry, Advanced breast, Cancer, Hematology, medicine.disease, Androgen receptor, Internal medicine, medicine, Biomarker (medicine), business, Antiestrogen therapy
Published
2017
Full Text
View/download PDF

11. Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra-patient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program

Author

Andrea Rocca, J-L. Albérini, Oriana Nanni, D. Marra, Arnoldo Piccardo, Federica Matteucci, J. Cortes, Tom Degenhardt, D. Andreis, Alessandra Gennari, Paolo Bruzzi, Davide Corradengo, Dino Amadori, G. Gebhart, E. Muñoz Couselo, Etienne Brain, Nadia Harbeck, Andrea Decensi, Romain Geiss, and C. Brambati

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Metastatic breast cancer, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Molecular imaging, business
Published
2017
Full Text
View/download PDF

13. The patients' understanding of clinical research

Author

Rudnas, B., primary, Montanari, E., additional, Dall'Agata, M., additional, Petracci, E., additional, Serra, P., additional, Piancastelli, A., additional, Vertogen, B., additional, Zumaglini, F., additional, Venturini, B., additional, Testoni, S., additional, Gallà, V., additional, Monti, M., additional, Andreis, D., additional, Pagan, F., additional, Ragazzini, A., additional, Fabbri, F., additional, Gentili, G., additional, Affatato, A., additional, and Nanni, O., additional

Published
2016
Full Text
View/download PDF

15. The patients' understanding of clinical research

Author

A. Affatato, A. Piancastelli, Flavia Pagan, G. Gentili, D. Andreis, Manlio Monti, Angela Ragazzini, Francesco Fabbri, F. Zumaglini, B. Venturini, Bernadette Vertogen, Sara Testoni, Monia Dall'Agata, Patrizia Serra, E. Petracci, Valentina Gallà, Oriana Nanni, E. Montanari, and Britt Rudnas

Subjects
medicine.medical_specialty, Clinical research, Oncology, business.industry, medicine, Hematology, Intensive care medicine, business
Published
2016
Full Text
View/download PDF

16. Nurses and Clinical Research Coordinators (CRCs) collaboration to improve quality in clinical trials

Author

Zeneli, A., primary, Serra, P., additional, Rosanna, T., additional, Marina, B., additional, Andreis, D., additional, Arjocan, O.R., additional, Gallà, V., additional, Golinucci, M., additional, Fabbri, F., additional, Braghesiu, P., additional, Gentili, G., additional, Zavoiu, V., additional, Nanni, C., additional, Monti, M., additional, Filograna, A., additional, Fiumicelli, T., additional, Ragazzini, A., additional, Beniamino, F., additional, Testoni, S., additional, Barlati, I., additional, and Nanni, O., additional

Published
2015
Full Text
View/download PDF

17. “Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience”

Author

Andreis, F., primary, Liborio, N., additional, Meriggi, F., additional, Codignola, C., additional, Anna, R., additional, Bertocchi, P., additional, Aroldi, F., additional, Abeni, C., additional, Ogliosi, C., additional, Rota, L., additional, Prochilo, T., additional, Di Biasi, B., additional, Mirandola, M., additional, and Zaniboni, A., additional

Published
2015
Full Text
View/download PDF

18. IRST WL: a tool to measure the workload of clinical research coordinators in oncology

Author

Fabbri, F., primary, Vertogen, B., additional, Serra, P., additional, Andreis, D., additional, Dall'Agata, M., additional, Gallà, V., additional, Gentili, G., additional, Massa, I., additional, Montanari, E., additional, Monti, M., additional, Pagan, F., additional, Piancastelli, A., additional, Polli, V., additional, Ragazzini, A., additional, Rudnas, B., additional, Testoni, S., additional, Venturini, B., additional, Zumaglini, F., additional, and Nanni, O., additional

Published
2015
Full Text
View/download PDF

19. Nurses and Clinical Research Coordinators (CRCs) collaboration to improve quality in clinical trials

Author

C. Nanni, F. Beniamino, T. Fiumicelli, Venetia Zavoiu, T. Rosanna, D. Andreis, Angela Ragazzini, A. Zeneli, O.R. Arjocan, Oriana Nanni, M. Golinucci, P. Braghesiu, Francesco Fabbri, A. Filograna, G. Gentili, Patrizia Serra, I. Barlati, Manlio Monti, B. Marina, Valentina Gallà, and Sara Testoni

Subjects
Clinical trial, medicine.medical_specialty, Clinical research, Oncology, business.industry, media_common.quotation_subject, medicine, Quality (business), Medical physics, Hematology, business, media_common
Published
2015
Full Text
View/download PDF

20. 'Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience'

Author

Paola Bertocchi, Chiara Abeni, Mara Mirandola, B. Di Biasi, R. Anna, Tiziana Prochilo, Chiara Ogliosi, Claudio Codignola, Francesca Aroldi, Federica Andreis, Nadia Liborio, A. Zaniboni, Luigina Rota, and Fausto Meriggi

Subjects
medicine.medical_specialty, Oncology, business.industry, Family medicine, medicine, Cancer, Observational study, Hematology, medicine.disease, business
Published
2015
Full Text
View/download PDF

21. IRST WL: a tool to measure the workload of clinical research coordinators in oncology

Author

Angela Ragazzini, Francesco Fabbri, Oriana Nanni, G. Gentili, Monia Dall'Agata, Manlio Monti, Patrizia Serra, B. Venturini, D. Andreis, Ilaria Massa, A. Piancastelli, Valentina Gallà, E. Montanari, V. Polli, Britt Rudnas, Flavia Pagan, F. Zumaglini, Bernadette Vertogen, and Sara Testoni

Subjects
medicine.medical_specialty, Clinical research, Oncology, business.industry, medicine, Measure (physics), Medical physics, Workload, Hematology, business, Intensive care medicine
Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results